MENU
ANTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

AN2 Therapeutics (ANTX) Earnings Date & Reports

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform... Show more

A.I. Advisor
published Earnings

ANTX is expected to report earnings to rise 41.67% to -25 cents per share on March 31

AN2 Therapeutics ANTX Stock Earnings Reports
Q4'26
Est.
$-0.25
Q2'26
Beat
by $0.05
Q1'26
Missed
by $0.06
Q4'25
Missed
by $0.07
Q3'25
Est.
$-0.31
The last earnings report on August 11 showed earnings per share of -18 cents, beating the estimate of -23 cents. With 582.00 shares outstanding, the current market capitalization sits at 150.94M.